Anticipation under § 102
Anticipation is the most stringent form of invalidity. A claim is anticipated if a single prior-art reference discloses every element of the claim, arranged as in the claim, in a manner that enables a person of ordinary skill in the art to make and use the invention. The doctrine is straightforward in form but exacting in application, and it remains the cleanest way for an accused infringer to defeat a patent.
The rule
A claim is anticipated under § 102 when a single prior-art reference discloses, expressly or inherently, each and every limitation of the claim, arranged or combined in the same way as in the claim, and the reference is enabling. Anticipation requires identity, not approximation. If even one limitation is missing, or if the limitations appear in the reference but are not arranged as the claim requires, anticipation fails — although the same reference may still support an obviousness challenge under § 103.
The single-reference rule is a defining feature. Combinations of two or more references cannot anticipate; they may only render a claim obvious. The rule's strictness is balanced by the doctrine of inherency, which allows a reference to disclose a limitation that is necessarily present even if not stated in haec verba.
Statutory and constitutional source
Section 102 of the Patent Act sets out the categories of prior art and the conditions under which an invention is novel. The Leahy-Smith America Invents Act of 2011 substantially rewrote § 102, replacing the historic first-to-invent system with a first-inventor-to-file system. The amended statute applies to patent applications and patents that contain or contained at any time a claim with an effective filing date on or after March 16, 2013. Patents whose effective filing dates are earlier are governed by the pre-AIA version of § 102.
Pre-AIA § 102 (effective filing dates before March 16, 2013)
Pre-AIA § 102 enumerated several categories that barred patentability. The most important were § 102(a) (knowledge or use by others in this country, or printing or patenting anywhere, before the applicant's invention date), § 102(b) (the statutory bars: printed publication or public use or sale more than one year before the U.S. filing date), § 102(e) (prior-filed but later-issued U.S. patents and published applications), and § 102(g) (prior invention by another not abandoned, suppressed, or concealed).
Post-AIA § 102 (effective filing dates on or after March 16, 2013)
Post-AIA § 102(a)(1) bars patenting an invention that was "patented, described in a printed publication, or in public use, on sale, or otherwise available to the public" before the effective filing date of the claim. Section 102(a)(2) bars patenting an invention "described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b)" filed before the effective filing date by another inventor. Section 102(b) provides one-year grace-period exceptions for the inventor's own disclosures and disclosures derived from the inventor.
The AIA eliminated the geographic limitations that had restricted certain pre-AIA categories to activity within the United States. Public use, on-sale, and "otherwise available to the public" prior art under post-AIA § 102(a)(1) reaches activity anywhere in the world.
The framework the courts apply
The single-reference rule
Anticipation requires that "each and every element as set forth in the claim is found, either expressly or inherently described, in a single prior art reference." Verdegaal Bros., Inc. v. Union Oil Co. of Cal., 814 F.2d 628 (Fed. Cir. 1987). A second reference cannot supply a missing limitation for anticipation purposes. A patentee who shows that any element of the claim is absent from the reference defeats the anticipation theory, although the absent element may still be supplied by another reference for an obviousness analysis.
The every-element rule and arrangement
It is not enough that the reference contains all the limitations scattered through its disclosure. The reference must show the elements arranged or combined in the same way as required by the claim. Net MoneyIN, Inc. v. VeriSign, Inc., 545 F.3d 1359 (Fed. Cir. 2008). A reference that discloses each limitation but in a different combination, or as alternatives in a list of options, does not anticipate unless the disclosure itself directs the skilled artisan to the claimed combination.
The inherency doctrine
Anticipation may be express or inherent. A limitation is inherently disclosed if it is necessarily present in what the reference describes, even if the reference does not articulate it. Inherency may not be established by probabilities or possibilities; the missing matter must be the natural result flowing from the reference's express disclosure. Schering Corp. v. Geneva Pharmaceuticals, Inc., 339 F.3d 1373 (Fed. Cir. 2003), held that an earlier patent disclosing the administration of a parent drug inherently anticipated later claims to the metabolite that the body necessarily produced when the parent compound was administered, even though the metabolite had not been identified at the time of the earlier disclosure.
Enablement of the prior art
To anticipate, a reference must place the invention in the possession of a person of ordinary skill — the reference must be enabling. In re Hafner, 410 F.2d 1403 (C.C.P.A. 1969), is the canonical authority for the proposition that a non-enabling disclosure cannot anticipate. The standard for prior-art enablement differs from § 112 enablement: the reference need only enable the relevant subject matter, not teach how to make and use it for any particular utility, and a presumption of enablement attaches to issued patents and printed publications. Amgen Inc. v. Hoechst Marion Roussel, Inc., 314 F.3d 1313 (Fed. Cir. 2003).
The Supreme Court applied a related enablement principle to issued-patent prior art under § 102(e) in Amgen Inc. v. Sanofi, 598 U.S. 594 (2023), although Amgen primarily addresses § 112 enablement of genus claims. See written description and enablement.
Priority dates
The anticipation analysis turns on the effective filing date of the challenged claim and the date of the asserted prior art. A patent claim's effective filing date may be earlier than its actual filing date if the application properly claims priority under § 119 to a foreign application or under § 120 to an earlier U.S. application — but only if the earlier application provides § 112 written-description and enablement support for the claim. A claim that lacks priority support is entitled only to its actual filing date, which may expose it to intervening prior art.
Burden and proof
An issued patent is presumed valid under 35 U.S.C. § 282(a). An accused infringer must prove anticipation in district court by clear and convincing evidence. Microsoft Corp. v. i4i Limited Partnership, 564 U.S. 91 (2011). The same standard governs the prior-art status of references and any factual predicates such as inherent disclosure.
In inter partes review before the PTAB, the burden is preponderance of the evidence. 35 U.S.C. § 316(e). The lower threshold is one of the structural reasons IPR has become a frequent forum for novelty-based challenges. Anticipation is a question of fact reviewed for substantial evidence on appeal from the PTAB and for clear error after a bench trial; jury verdicts on anticipation are reviewed for substantial evidence as well.
Interaction with related doctrines
Anticipation and obviousness share the same prior-art universe but operate differently: anticipation requires identity in a single reference, while obviousness permits combinations and considers whether differences would have been obvious. A reference that fails to anticipate often supports an obviousness theory, and counsel routinely plead both.
Anticipation interacts with claim construction. The scope of the claim, fixed by construction, defines what the prior art must disclose. A construction adopted to capture the accused product may also broaden the claim against the prior art — the so-called "that which infringes if later, anticipates if earlier" principle from Peters v. Active Manufacturing Co., 129 U.S. 530 (1889).
The on-sale and public-use bars are anticipation provisions in their own right. See on-sale bar and public use bar. Both are housed within § 102 and have generated extensive case law on what counts as a "sale," a "public use," and the AIA's "otherwise available to the public" residual category.
Practical notes
An anticipation defense begins with a careful claim chart that places each limitation alongside text and figures from the asserted reference. Where the reference is silent on a limitation, the defense must articulate an inherency theory and identify factual support. Expert testimony is ordinarily required to establish the perspective of a person of ordinary skill and to interpret technical disclosures.
Date proof matters. The defense must establish the prior-art date of the reference — the date of public availability for a printed publication, the filing date for a § 102(e) reference, the date of public use or sale for a use- or sale-based bar. Patentees frequently challenge the public-availability proof for obscure references such as conference handouts, theses, or product manuals. The Federal Circuit's case law on what makes a document a "printed publication" is fact-intensive and turns on dissemination, indexing, and accessibility to interested members of the public.
In inter partes review, the petitioner is limited to "patents or printed publications." 35 U.S.C. § 311(b). Public-use, on-sale, and prior-art categories that depend on activities rather than documents are not available in IPR. Those defenses must be raised in district court or in post-grant review, when available.
Open questions
The full scope of the AIA's "otherwise available to the public" language in post-AIA § 102(a)(1) has not been definitively resolved. The Federal Circuit held in Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc., 855 F.3d 1356 (Fed. Cir. 2017), aff'd, 586 U.S. 123 (2019), that the on-sale bar continues to apply to secret sales when the existence of the sale is publicly known, but courts have not fully mapped the boundaries of "otherwise available to the public" for other forms of disclosure. Whether and how the AIA narrowed or broadened pre-AIA categories remains the subject of ongoing litigation.
The interplay between AIA § 102(b) grace-period exceptions and intervening third-party disclosures, and the application of the derivation framework that replaced interferences, are also still developing. The PTAB and the Federal Circuit will continue to refine these issues as more AIA-era patents reach litigation.
See also
- Obviousness under § 103The companion novelty-related doctrine that permits combinations of references.
- On-sale barA § 102 anticipation provision triggered by commercial sales activity.
- Public use barA § 102 anticipation provision triggered by public use of the invention.
- Claim constructionDefines the scope that the prior art must disclose to anticipate.
- Inter partes reviewThe PTAB forum for patent and printed-publication-based novelty challenges.
- IPR estoppelLimits a petitioner's ability to relitigate § 102 grounds raised or reasonably could have been raised.
- KSR v. TeleflexFrames how a single reference relates to the broader obviousness inquiry.
Last reviewed: 2026